(ALNY) Alnylam - Performance 32.4% in 12m
ALNY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
53.44%
#7 in Peer-Group
Rel. Strength
76.38%
#1755 in Stock-Universe
Total Return 12m
32.36%
#33 in Peer-Group
Total Return 5y
111.28%
#10 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 326.09 USD |
| 52 Week Low | 224.32 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 79.00 |
| Buy/Sell Signal +-5 | 0.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ALNY (32.4%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ALNY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALNY
| Total Return (including Dividends) | ALNY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 5.22% | 2.27% | 4.52% |
| 3 Months | 25.92% | 6.30% | 10.43% |
| 12 Months | 32.36% | -10.68% | 14.67% |
| 5 Years | 111.28% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | ALNY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 85.5% | 5.5% | 79.1% |
| 3 Months | 94.2% | 74.3% | 94.2% |
| 12 Months | 20% | -84.7% | 44.4% |
| 5 Years | 69.2% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th69.00 | 2.88% | 0.67% |
| 3 Month | %th73.50 | 18.46% | 14.03% |
| 12 Month | %th84.00 | 48.18% | 15.43% |
| 5 Years | %th96.00 | 186.02% | 0.98% |
FAQs
Does Alnylam (ALNY) outperform the market?
Yes,
over the last 12 months ALNY made 32.36%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months ALNY made 25.92%, while XBI made 6.30%.
Performance Comparison ALNY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ALNY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.7% | 0.7% | 31.6% | 18% |
| US NASDAQ 100 | QQQ | -2.2% | 0.6% | 30.4% | 18% |
| German DAX 40 | DAX | -1% | 6.3% | 20.1% | 4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.7% | 1.1% | 30.7% | 15% |
| Hongkong Hang Seng | HSI | -1% | -0.8% | 13.8% | -4% |
| India NIFTY 50 | INDA | -2.8% | 2.8% | 33.3% | 32% |
| Brasil Bovespa | EWZ | -3.8% | -2.3% | 8.7% | 19% |
ALNY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.3% | -0.8% | 26.5% | 5% |
| Consumer Discretionary | XLY | -2.1% | 3.2% | 38.8% | 12% |
| Consumer Staples | XLP | -1.7% | 5.6% | 32% | 22% |
| Energy | XLE | -1.6% | 0.9% | 37.7% | 36% |
| Financial | XLF | -3% | 1.6% | 27.9% | 3% |
| Health Care | XLV | -3.1% | 1.7% | 37.7% | 36% |
| Industrial | XLI | -2.9% | 1.1% | 24.4% | 8% |
| Materials | XLB | -3.7% | 1% | 28.5% | 27% |
| Real Estate | XLRE | 0.4% | 4.5% | 32.8% | 19% |
| Technology | XLK | -2.4% | -2.7% | 29.3% | 22% |
| Utilities | XLU | -1.3% | 4.8% | 28.9% | 8% |
| Aerospace & Defense | XAR | -3.4% | -2% | 13.2% | -17% |
| Biotech | XBI | -0% | 3% | 47.1% | 43% |
| Homebuilder | XHB | -5.3% | -5.3% | 38.2% | 27% |
| Retail | XRT | -3.7% | 0.8% | 37.3% | 23% |
ALNY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.2% | -1.08% | 41.8% | 42% |
| Natural Gas | UNG | 6.1% | 15.7% | 49% | 41% |
| Gold | GLD | -1.3% | 6.5% | 12.5% | -10% |
| Silver | SLV | -1.3% | 1.6% | 16.3% | 10% |
| Copper | CPER | -3.8% | 1.3% | 13.2% | 17% |
ALNY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.8% | 1.7% | 35.4% | 31% |
| iShares High Yield Corp. Bond | HYG | -0.9% | 4% | 33.7% | 22% |